Hamilton Introduces GlucoSense to Make Real-Time Glucose Monitoring Routine in Bioprocessing

Hamilton announced the launch of GlucoSense, a breakthrough in bioprocess analytics that introduces the first reusable, in situ glucose sensor designed t...

December 17, 2025 | Wednesday | News
Lindus Health and Quotient Sciences Form Strategic Partnership to Accelerate Early-Phase Clinical Development

Lindus Health, the "anti-CRO" running radically faster, more  reliable clinical trials for life science pioneers, and Quotient Sciences, a leading g...

December 17, 2025 | Wednesday | News
Minghui Pharma Secures FDA IND Clearance to Launch Global Phase 3 Trials of MHB018A in Thyroid Eye Disease

Minghui Pharmaceutical, a late-stage biopharmaceutical company dedicated to developing transformative medicines in immunology and oncology, today announc...

December 16, 2025 | Tuesday | News
Vanda Targets Mid-2026 Approval With Imsidolimab BLA for Generalized Pustular Psoriasis

Vanda Pharmaceuticals Inc.  announced the submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for ims...

December 16, 2025 | Tuesday | News
RedHill Biopharma Highlights Opaganib as Potential Add-On Therapy for Venetoclax-Resistant CLL

Resistance to venetoclax (Venclexta® and Venclyxto®, Abbvie / Genentech), the $2.5 billion blockbuster Chronic Lymphocytic Leukemia (CL...

December 16, 2025 | Tuesday | News
Anova Launches Free AI-Powered Patient Matching Platform to Accelerate Clinical Trial Enrollment

Anova launches a free AI-enabled patient matching solution that uses proprietary algorithms to connect patients to 200,000+ open clinical trials with...

December 15, 2025 | Monday | News
Prilenia and Ferrer Receive FDA Clearance to Begin 500-Patient Pivotal Phase 3 ALS Study of Pridopidine

Prilenia Therapeutics B.V. and Ferrer  announced that the US Food and Drug Administration (FDA) has cleared the start of the pivotal, 500-patient, r...

December 12, 2025 | Friday | News
China Approves InnoCare’s Breakthrough TRK Inhibitor Zurletrectinib for Adult and Adolescent Solid Tumors

InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company, announced that its next-generation TRK inhibitor, zurletrectinib (ICP-72...

December 12, 2025 | Friday | News
Oxford BioTherapeutics and GSK Launch Multi-Year Collaboration to Develop Novel Antibody-Based Cancer Therapies

Collaboration leverages OBT's proprietary OGAP®-Verify platform and GSK's drug development expertise to advance multiple selected novel oncology ta...

December 11, 2025 | Thursday | News
Ginkgo Bioworks Joins Deep Origin To Build ARPA H Funded Computational Drug Safety Platform

Ginkgo Bioworks  announced its partnership with Deep Origin on a 4.5-year project funded by the Advanced Research Projects Agency for Health (ARPA-H...

December 10, 2025 | Wednesday | News
Zai Lab Medicines Renewed in China’s 2025 National Reimbursement Drug List

Zai Lab Limited  announced that the following medicines and indications have been renewed in the 2025 National Reimbursement Drug List (NRDL) releas...

December 08, 2025 | Monday | News
Incyte Announces FDA Breakthrough Therapy Designation for INCA033989 for Essential Thrombocythemia with Type 1 CALR Mutation

Incyte  announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to INCA033989, a first-in-class muta...

December 08, 2025 | Monday | News
Quotient Sciences Announces Strategic Multi-Year Partnership with Intrepid Labs to Accelerate AI-Driven Early Drug Development

Quotient Sciences, a leading global drug development, research and manufacturing accelerator, and Intrepid Labs, the AI leader in pharmaceutical formulat...

December 08, 2025 | Monday | News
LabGenius Therapeutics Announces Second Collaboration With Sanofi to Co-Optimise Therapeutic NANOBODY® Molecules

LabGenius Therapeutics (“LabGenius”), a drug discovery company combining machine learning (ML) and high-throughput experimentation to o...

December 05, 2025 | Friday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close